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FiberAdenovirus (Ad) endosomal membrane penetration activates the NLRP3 inﬂammasome by releasing
lysosomal cathepsin B (catB) into the cytoplasm. We therefore examined the extent to which inﬂammasome
activation correlates with Ad colocalization with catB-enriched lysosomes. Inﬂammasome activation, is
greater during infections with Ad5 possessing an Ad16 ﬁber (Ad5F16gfp), or Ad5gfp neutralized by human
serum, than Ad5gfp alone. Enhanced IL-1β release by Ad5F16gfp is partially due to increased TLR9 signaling
but also correlates with greater release of catB into the cytoplasm. This increased TLR9 signaling and catB
release correlates with a greater localization of Ad5F16gfp to lysosomes prior to endosomal escape. Another
nonenveloped virus, reovirus, requires catB to penetrate cell membranes. However, reovirus did not release
catB into the cytoplasm despite signiﬁcantly greater colocalization with lysosomes compared to Ad5gfp and
efﬁcient membrane penetration. Thus, not only lysosomal localization, but the mechanism of membrane
penetration inﬂuences viral activation of the NLRP3 inﬂammasome.logy and Immunology, Loyola
105, Rm. 3818, 2160 S. First
4.
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Cells have evolved numerous strategies to sense invading viruses
and initiate innate antiviral mechanisms which limit viral replication
and recruit cells of the immune system to help clear infected cells.
These strategies involve the recognition of virus associated molecules
such as nucleic acids via Toll-like receptors (TLRs) and RIG-I-like
Helicases (RLHs) (Kawai and Akira, 2008), or viral glycoproteins by
TLRs (Boehme et al., 2006; Compton et al., 2003; Kurt-Jones et al.,
2004). It is also becoming increasingly apparent that cell-derived
danger signals, produced in response to viral infection, serve as
additional stimuli for innate antiviral responses. These danger signals
have been found to include oxidized lipids and nuclear protein-
derived “alarmins” such as HMGB1 or S100-family proteins (Bianchi,
2007; Wang et al., 2006). More recently, rupture of lysosomes and
oxidative stress in response to adenovirus (Ad) cell entrywas found to
trigger the activation of the NOD-like receptor, NLRP3 (Barlan et al.,
2011).
Adenoviruses are a family of nonenveloped dsDNA viruses
commonly associated with acute upper respiratory, gastrointestinal
and ocular infections. Over 50 human serotypes of Ad have been
identiﬁed to date, which are currently split among seven subgroups
based on hemagglutination properties and sequence homology(Benko and Harrach, 2003). Adenovirus infections are associated
with acute inﬂammation which is known to be elicited by incoming
virions (Cerullo et al., 2007; Di Paolo et al., 2009; Iacobelli-Martinez
and Nemerow, 2007;Muruve, 2004; Muruve et al., 2008; Nociari et al.,
2009, 2007; Zhu et al., 2007). To better understand the potential
mechanisms through which Ad elicits a proinﬂammatory response, a
description of the cell entry process is warranted.
To enter cells, Ads ﬁrst bind to a primary attachment receptor via
high afﬁnity interactions between the virus ﬁber protein and the cell
surface receptor (Howitt et al., 2003). For subgroups A, C, E and F, this
receptor is the coxsackievirus and adenovirus receptor (Howitt et al.,
2003). For subgroup B and D viruses, this receptor has been found to
be CD46, sialic acid or CD80/CD86 (Sakurai et al., 2007). Heparan
sulfate proteoglycans can also mediate ﬁber-dependent infection by
some subgroup B viruses (Tuve et al., 2008). After attachment,
secondary engagement of alphav integrins by the RGD motif of the
viral penton base protein induces a signal cascade which leads to
clathrin mediated endocytosis of virions (Nemerow, 2000). Adenovi-
rus engagement of αv integrins has been linked to proinﬂammatory
signals such as NF-kappaB activation (Muruve, 2004). Although, it is
difﬁcult to rule out the contributions of additional downstream events
in the entry process to this signaling event since preventing penton
base interactions with integrins prevent subsequent entry steps.
Within endosomes, the virus begins a stepwise disassembly
process (Greber et al., 1993) which correlates with acidiﬁcation of
the endosomal compartment by the vacuolar ATPase proton pump.
This disassembly process is strictly required for virus escape from
endosomes (Wiethoff et al., 2005). Disassembly in endosomes also
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Fig. 1. Efﬁciency of Ad-induced IL-1β release. PMA-differentiated THP-1 cells were
rested in SFM for 2 h before treatment with increasing MOIs of Ad5gfp (♦), Ad5gfp+
10% human serum (■) or Ad5F16gfp (▲) for 6 h. Release of IL-1β into supernatant was
determined by ELISA. Data represent the mean and standard error of 3 replicates.
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TLR9 leading to the production of TNF-α, IL-6 and type I interferons
(Zhu et al., 2007). One of the proteins released from the viral capsid
during this disassembly process, protein VI, is membrane lytic and
mediates the endosomal escape of partially disassembled virions by
still poorly deﬁned mechanisms (Wiethoff et al., 2005; Maier et al.,
2010). Activation of p38 and ERK1/2map kinases in amannerwhich is
dependent upon Ad membrane penetration is another previously
described proinﬂammatory signal elicited by Ad infection (Tibbles
et al., 2002). Once in the cytoplasm, the virusmoves alongmicrotubules
in a dynein-dependent manner towards the nucleus. Although the
mechanisms remain unknown, evidence exists for the cytosolic
detection of Ad leading to the activation of IRF3 and resulting in the
production of interferon-β (Zhu et al., 2007).
Most recently, recognition of Ad by the NLRP3 inﬂammasome was
shown to mediate the release of IL-1β (Muruve et al., 2008). NLRP3
contains an N-terminal pyrin domain, a central NACHT domain,
NACHT-associated domain and 7 C-terminal leucine rich repeats (Ye
and Ting, 2008). Numerous stimuli can activate the NLRP3 inﬂamma-
some by induction of reactive oxygen species or release of lysosomal
cathepsins into the cytoplasm (Hornung and Latz; 2010 Schroder
et al., 2010; Tschopp and Schroder, 2010). We have shown that Ad5
recognition by TLR9 in human macrophages primes the inﬂamma-
some by inducing expression of NLRP3 and ASC (Barlan et al., 2011).
Additionally, Ad5 protein VI-mediated rupture of lysosomal mem-
branes during cell entry leads the cathepsin B- and ROS-dependent
activation of the NLRP3 inﬂammasome. Adenovirus activation of the
inﬂammasome leads to release of the cytokine IL-1β. Inﬂammasome
activation by Ad5 also leads to NLRP3 and cathepsin B-dependent,
but caspase-1-independent, necrotic cell death of macrophages
resulting in the release of the proinﬂammatory molecule HMGB1.
Thus, rupture of cathepsin-enriched lysosomes during Ad cell entry
serves as a danger signal leading to release of proinﬂammatory
mediators.
Since numerous studies have highlighted differences in intracel-
lular trafﬁcking of Ads from different subgroups with subgroup C
viruses thought to penetrate endosomal membranes at very early
times post-endocytosis and subgroup B viruses localizing with late
endosomes and lysosomes prior to endosomal membrane penetration
(Miyazawa et al., 2001, 1999; Shayakhmetov et al., 2003), we sought
to determine whether these differences in Ad endosomal sorting
would inﬂuence NLRP3 inﬂammasome activation. Using Ad5 vectors
possessing either Ad5 (Ad5gfp) or Ad16 knob domains (Ad5F16gfp),
we ﬁnd that although these viruses penetrate endosomal membranes
with similar efﬁciency, greater localization of Ad5f16gfp to cathepsin-
enriched lysosomes prior to endosomal escape leads to enhanced
cytosolic release of cathepsins and augmented ROS production
compared to Ad5gfp.
We also examined whether lysosomal rupture was a common
danger signal recognized by cells during cell entry by other none-
nveloped viruses. Reoviruses are a dsRNA nonenveloped virus which
depends on lysosomal cathepsins to penetrate cell membranes and is
therefore predicted to localize to cathepsin enriched lysosomes for
productive infection. While we do observe lysosomal localization of
reovirus T3D and T1L in macrophage-like THP-1 cells, release of
cathepsin B into the cytoplasm is not observed. Furthermore, reovirus
induced IL-1β release is also not observed, suggesting that not only
the location, but also the mechanism of nonenveloped virus
endosomal escape dictates whether cathepsin-dependent inﬂamma-
some activation occurs during virus cell entry.
Results
We have previously demonstrated that Ad activation of the
NLRP3 requires release of lysosomal cathepsins into the cytoplasm
during viral penetration of endosomal membranes (Barlan et al.,2011). Previous studies have suggested that Ads possessing the Ad5
(subgroup C) or Ad3 (subgroup B) knob can both activate the
inﬂammasome (Muruve et al., 2008). Several studies have
suggested that Ads of subgroup B colocalize with late endosomal
and lysosomal markers prior to endosomal escape to a greater
extent than subgroup C viruses (Miyazawa et al., 2001, 1999;
Shayakhmetov et al., 2003) suggesting that subgroup B viruses may
induce greater release of lysosomal cathepsins upon endosomal
rupture. Additionally, it was recently demonstrated that Ad5
neutralization by antibodies present in pooled human serum prior
to infection of THP-1 cells augmented the extent of the Ad-induced
proinﬂammatory response including greater activation of the NLRP3
inﬂammasome (Zaiss et al., 2009). The mechanism of enhanced
inﬂammasome activation was not described, however.
We ﬁrst examinedwhether the extent of inﬂammasome activation
was inﬂuenced by the route of Ad cell entry. PMA-differentiated THP-
1 cells were infected with increasing MOIs of Ad5gfp, Ad5gfp
incubated for 30 min in the presence of 10% heat inactivated, pooled
human serum (Ad5gfp+HS), or Ad5F16gfp, a recombinant Ad5gfp
vector in which the knob and shaft were replaced with that of Ad16
(Hsu et al., 2005), and IL-1β release into the supernatant was
determined 6 h post infection. Compared to Ad5gfp, Ad5gfp+HS and
Ad5f16gfp induced similar amounts of IL-1β at MOIs which were 30-
and 100-fold lower, respectively when comparing the MOI at which
IL-1β release above baseline is observed (Fig. 1). To rule out whether
the enhanced release of IL-1β observed for Ad5+HS and Ad5F16gfp
was due to more efﬁcient endosomal escape, we quantiﬁed Ad
endosomal escape using a previously described assay which monitors
the ability of Ads to facilitate the cytosolic translocation of the co-
endocytosed, membrane impermeable, ribosomal toxin, saporin
(Maier et al., 2010). Although the ability of Ad5gfp to deliver its
genome to the nucleus is greatly inhibited in the presence of pooled
human serum (data not shown and (Zaiss et al., 2009), other studies
have shown that the anti-hexon antibodies present in human serum
restrict Ad gene delivery at a step post-endosomal escape (Smith
et al., 2008; Varghese et al., 2004). PMA-differentiated THP-1 cells
were treated with increasing MOIs of Ad5gfp, Ad5+HS and
Ad5F16gfp in the presence of saporin and saporin-dependent
cytotoxicity was assessed 24 h post infection by MTT assay. While
Ad5gfp+HS and Ad5F16gfp could more efﬁciently induce IL-1β
release, each virus was similarly efﬁcient in facilitating the saporin
translocation into the cytoplasm as assessed by MTT assay (Fig. 2A).
We have previously shown that TLR9 recognition of the Ad5
genome primes the NLRP3 inﬂammasome in human cells by
stimulating the expression of NLRP3, ASC and proIL-1β, while
Ad5-induced release of lysosomal cathepsin B into the cytoplasm
Fig. 2. Correlation of inﬂammasome activation with Ad membrane permeabilization, TLR9 signaling and cathepsin B release into the cytoplasm. A) PMA-differentiated THP-1 cells
were rested in SFM for 2 h before treatment with increasing MOIs of Ad5gfp (♦), Ad5gfp+10% human serum (■), or Ad5F16gfp (▲) for 6 h in the presence of Saporin. Cells were
then washed, incubated overnight and subjected to an MTT assay to assess cell viability. Data represent the mean and standard error of 3 replicates. B) PMA-differentiated THP-
1tlr9KD cells stably expressing TLR9 speciﬁc shRNA were rested in SFM for 2 h before priming with 30 ng/ml of TLR2 agonist Pam3CSK4 for 2 h, followed by treatment with
increasing MOI of Ad5gfp (♦), Ad5gfp+10% human serum (■), or Ad5F16gfp (▲) for 2 h. Release of IL-1βwas determined by ELISA. Data represent the mean and standard error of 3
replicates. Inset: western blot of cell lysates for TLR9 from THP-1cntrl and THP-1tlr9KD cells stably expressing control or tlr9 speciﬁc shRNA, respectively. C) Cells were not treated
(NT), treated with 1000 GTU-equivalents of ts1, 100, 300 or 1000 GTU of Ad5gfp or 30, 100, or 300 GTU of Ad6F16gfp or Ad5gfp+10% human serum for 1 h. Cytosolic extracts from
digitonin permeabilized cells were analyzed for cathepsin B by western blot. Extraction with 1% triton X-100 (TX100) was performed as a positive control.
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and Ad5gfp+HS were both previously shown to localize more
strongly with lysosomes than Ad5gfp in epithelial cells and THP-1
cells, respectively. Lysosomes are enriched for TLR9 and cathepsin B.
Thus greater signaling through TLR9 to prime the NLRP3 inﬂamma-
some and greater cytosolic release of cathepsin B which activates
the NLRP3 inﬂammasome could both explain the greater release of
IL-1β by Ad5F16gfp and Ad5gfp+HS from THP-1 cells. Ad5F16gfp
was previously shown to induce greater secretion of interferon-α
from human PBMCs than Ad5gfp in a TLR9-dependent manner
(Iacobelli-Martinez and Nemerow, 2007). It was also recently
shown that Ad5+HS leads to an overall increase in the expression
of several proinﬂammatory cytokines compared to Ad5 alone (Zaiss
et al., 2009). Thus enhanced TLR9 signaling by Ad5F16gfp and
Ad5gfp+HS likely contributes to greater priming of the NLRP3
inﬂammasome. However, since Ad5F16gfp and Ad5gfp+HS rupture
endosomes with similar efﬁciency as Ad5gfp alone, we next
examined whether the extent to which increased cathepsin B
release into the cytoplasm contributes to greater inﬂammasome
activation by Ad5F16gfp and Ad5gfp+HS. To determine the extent
to which adenovirus lysosomal localization and cathepsin B release
enhances NLRP3 activation, we used cells in which TLR9 was stably
knocked down to reduce adenovirus priming of the inﬂammasome.
We primed PMA-differentiated THP-1 cells stably expressing TLR9
shRNA and THP-1tlr9KD, with the TLR2 agonist, PAM3CSK4, for 2 h
to induce expression of inﬂammasome components before infecting
cells with increasing MOIs of Ad5gfp, Ad5gfp+HS or Ad5F16gfp for
2 h. Under these conditions, inﬂammasome priming via TLR2
effectively normalizes the priming process for all viral treatments.
We observed that Ad5F16gfp and Ad5gfp+HS released similar
amounts of IL-1β as Ad5gfp at only 3-fold lesser MOIs when
comparing the MOI at which IL-1β is released above baseline
(Fig. 2B). The expression of TLR9 was reduced ~70% as assessed by
western blot (Fig. 2B, inset). These results suggest that when
priming of the NLRP3 inﬂammasome is equivalent among the viraltreatments, Ad5F16gfp and Ad5gfp+HS still more potently induce
NLRP3-dependent IL-1β secretion compared to Ad5gfp.
The reported increased colocalization of Ad5+HS with lysosomal
markers in THP-1 cells and Ad5F16gfp in epithelial cells seems to
correlate with enhanced inﬂammasome activation in spite of the fact
that Ad5gfp, Ad5+HS and Ad5F16gfp all escape from endosomes
with similar efﬁciency. So we next examined whether the increased
IL-1β release in response to Ad5+HS and Ad5F16gfp correlated with
increased release of cathepsin B into the cytoplasm. PMA-differen-
tiated THP-1 cells were infected with equivalent amounts of Ad5gfp,
Ad5+HS or Ad5F16gfp for 2 h, cells were then washed extensively,
the plasma membrane was selectively permeabilized with digitonin
and the amount of cathepsin B in the cytosolic extract was examined
by western blot. Control infections with equivalent amounts of the
temperature sensitive mutant, ts1, which is unable to escape from
endosomes when produced at the nonpermissive temperature
(Cotten and Weber, 1995; Greber et al., 1996; Silvestry et al.,
2009; Wiethoff et al., 2005), were also performed. Infection with all
but ts1 facilitated release of lysosomal cathepsins into the cytoplasm,
suggesting viral membrane penetration was required for this event
(Fig. 2C). However, Ad5+HS and Ad5F16gfp membrane penetration
released substantially more cathepsin B into the cytoplasm com-
pared to Ad5gfp. Taken together, data in Fig. 2B and C suggest that
greater release of lysosomal cathepsin B into the cytoplasm by
Ad5F16gfp and Ad5gfp+HS contributes to their greater activation of
the NLRP3 inﬂammasome.
To determine whether the enhanced release of cathepsin B into
the cytoplasm by Ad5F16gfp was due to greater colocalization of the
virus with lysosomes, PMA-differentiated THP-1 cells were synchro-
nously infected with either ﬂuorescently labeled Ad5gfp, Ad5F16gfp
or ts1 for various times. Cells were ﬁxed and permeabilized before
immunostaining for the lysosomal marker, LAMP1 and counter-
staining the nuclei with DAPI. Fluorescence deconvolution images
were collected (Fig. 3A). Colocalization of virus with lysosomes was
quantiﬁed by determining the number of cytoplasmic puncta
Fig. 3. Lysosomal localization of adenovirus. PMA-differentiated THP-1 cells were plated on ﬁbronectin coated coverslips and infected with Dylight 488 NHS-Ester labeled Ad5gfp,
Ad5F16gfp, and ts1. Cells were then ﬁxed and permeabilized with Triton X-100. Localization of A) Ad5gfp (left) or Ad5F16gfp (right) with lysosomes was analyzed by
immunoﬂuorescence with monoclonal anti-LAMP1 and secondary Alexa Fluor 568-conjugated Abs, followed by nuclear counterstaining with Hoechst. The images show virus
(green), LAMP-1 (red), and nucleus (blue). C) The number of puncta positive for both virus and LAMP-1 was counted for 25 infected cells per treatment: Ad5 at 20 min (◊) and
60 min (Δ) post infection (mpi), Ad5F16 at 60 mpi (○), and ts1 at 20 mpi (×). The solid horizontal bar is the average number of puncta units of colocalization per cell for each virus.
309A.U. Barlan et al. / Virology 412 (2011) 306–314positive for ﬂuorescent virus (green) and LAMP1 (red) per cell.
Ad5gfp demonstrated a minimal colocalization with LAMP1 parti-
cles, with maximal observation of an average of 0.2 dual positive
puncta per cell observed at 1 h post internalization (Fig. 3B). This
was 5-fold less than the average value of 1.1 puncta per cell for
Ad6F16 at 1 h post internalization (p=0.007). Lysosomal localiza-
tion of ts1, which uses the same receptors and is endocytosed
similarly to Ad5gfp, is similar at 20 min to that observed for
Ad5F16gfp at 1 h (p=0.335), in agreement with observations that
Ad5gfp more efﬁciently escapes from endosomes prior to reaching
lysosomes (Miyazawa et al., 2001, 1999; Shayakhmetov et al., 2003).
This data suggest that there is a correlation between the extent of
lysosomal colocalization of Ad and cathepsin B-dependent activation
of the NLRP3 inﬂammasome.
Numerous nonenveloped viruses gain access to the cytoplasm by
penetrating endosomal membranes (Tsai, 2007). Thus release of
cathepsin B into the cytoplasm as these viruses penetrate lysosomal
membranes could be a common danger signal. Reoviruses are dsRNA
viruses which require endocytosis to penetrate cell membranes and
replicate in the cytoplasm (Danthi et al., 2010). The Dearing and Lang
strains of reovirus (T3D and T1L, respectively) require proteolytic
processing of the capsids by cathepsins B and L to penetrate cell
membranes (Ebert et al., 2002). Like Ads, cells respond to reovirus cell
entry by activating proinﬂammatory transcription factors IRF-3 andNF-kappaB (Danthi et al., 2008; Hansberger et al., 2007; Holm et al.,
2007). To determine whether reovirus releases cathepsin B into the
cytoplasm during cell entry, PMA differentiated THP-1 cells were
infected with Ad5F16gfp, reovirus T3D or T1L for 2 h and cathepsin B
in the cytoplasm was monitored by western blot as described above.
Compared to Ad5F15gfp, T3D induced no detectable release of
cathepsin B release into the cytoplasm and T1L released marginal
amounts (Fig. 4A).
Reovirus is not able to efﬁciently facilitate the cytosolic translo-
cation of ribosomal toxins such as saporin in THP-1 cells (unpublished
observation). So, to conﬁrm that both T3D and T1L penetrated
endosomal membranes, we assessed viral gene expression in PMA-
differentiated THP-1 cells. Cells were infected with T3D or T1L viruses
for 1 h. Excess virus was washed away and cells were either ﬁxed or
incubated for 8 h at 37 °C before cells were ﬁxed. Cells were then
permeabilized and immunostained with anti-μNS to quantify the
percentage of expressing viral proteins. While no signiﬁcant staining
was observed for cells after 1 h infection, 65% and 67% of cells stained
intensely after 8 h for T3D and T1L viruses, which suggests that
reovirus efﬁciently escaped from endosomes in these cells.
Since reovirus reportedly requires cathepsin B to enter ﬁbroblasts
and epithelial cells, we next determined the efﬁciency with which
reovirus localized to lysosomes in PMA-differentiated THP-1 cells.
Cells were infected for 1 h with T3D and T1L strains, then ﬁxed,
Fig. 4. Cathepsin B release into the cytoplasm and lysosomal localization of reovirus. A) PMA-differentiated THP-1 cells were treated with 1000 PFU/cell of reovirus T3D or T1L or 300
GTU of Ad5F16gfp for 2 h. Cytosolic extracts from digitonin permeabilized cells were analyzed for cathepsin B by western blot. B) PMA-differentiated THP-1 cells were plated on
ﬁbronectin coated coverslips and then synchronously infected with 1000 PFU/cell of T3D (left) TIL (right) for 1 h. Cells were then ﬁxed, permeabilized and immunostained with
polyclonal Abs to reovirus and mAb for LAMP-1 followed by secondary Alexa Fluor 488 and 568-conjugated Abs, respectively. Hoechst stain was used to counterstain nuclei. The
images show virus (green), LAMP-1 (red), and nucleus (blue). C) The number of dually labeled puncta was counted for 25 infected cells for each virus type. Each symbol is one
infected cell: T3D (□), T1L (◊). The solid horizontal bar is the average number of units of colocalization per cell for each virus.
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Fig. 5. Reovirus endosomal escape is not sufﬁcient for activation of the NLRP3
inﬂammasome in TLR primed cells. PMA-differentiated THP-1 cells were rested in SFM
for 2 h before prestimulation with 30 ng/ml Pam3CSK4 for 2 h. After prestimulating
cells, infected with 3000 PFU/Cell of T3D or T1L for 2 h and 300 GTU/cell Ad5gfp for 2 h.
IL-1β release was determined by ELISA. Data represent themean and standard error of 3
replicates.
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and anti-LAMP1 (Fig. 4B). The number of puncta per cell staining for
both reovirus and LAMP-1 was quantiﬁed as described above.
Compared to Ad5gfp, T3D and T1L viruses more strongly colocalized
with LAMP-1 positive vesicles (p=0.002 and 0.010, respectively)
similar to that observed for Ad5F16gfp and in agreement with the
requirement for lysosomal cathepsins to penetrate cell membranes
(Fig. 4C).
To determine whether reovirus activates the inﬂammasome
during cell entry, PMA-differentiated THP-1 cells were primed with
PAM3CSK4 for 2 h to ensure sufﬁcient expression of NLRP3, ASC and
proIL-1β before infecting with 1000 PFU/cell of reovirus T3D or T1L
or 300 GTU/cell of Ad5gfp for 2 or 1 h, respectively. Compared to
Ad5gfp, which induced release of signiﬁcantly more IL-1β than
PAM3CSK4 alone, reovirus did not induce IL-1β release above
control although present at a higher MOI than Ad5gfp (Fig. 5).
Additional experiments examining reovirus-induced release of IL-1β
311A.U. Barlan et al. / Virology 412 (2011) 306–314from PAM3CSK4 primed cells at 4 and 6 h post infection yielded
similar results (not shown). Thus, not only does the location of viral
membrane penetration within the endolysosomal system inﬂuence
NLRP3 activation, but the mechanism of viral membrane penetra-
tion may as well.
Discussion
Detection of a virus by the host during cell entry represents the
very earliest possible event leading to an innate and adaptive
immune response. Several nonenveloped viruses including adeno-
virus (Di Paolo et al., 2009; Iacobelli-Martinez and Nemerow, 2007;
Muruve et al., 2008; Nociari et al., 2009), reovirus (Holm et al.,
2007), and parvovirus (Zhu et al., 2009) are recognized by the host
while entering cells although the exact details have been incom-
pletely deﬁned. Adenovirus cell entry triggers numerous different
proinﬂammatory signaling pathways resulting in the activation of
MAPK, NF-kappaB, and IRF3/IRF7 dependent expression of proin-
ﬂammatory cytokines (Appledorn et al., 2008; Fejer et al., 2008;
Muruve, 2004; Nociari et al., 2009, 2007; Zhu et al., 2007), MHC II
and costimulatory molecules (Nociari et al., 2009, 2007), as well as
type I interferons, and subsequently, interferon stimulated genes
(Granberg et al., 2005; Scibetta et al., 2005; Zhao et al., 2003).
While a considerable amount of information is available regarding
the downstream molecules activated during adenovirus infection
and cell entry, much less is known regarding exactly which host cell
and viral molecules are necessary to initiate these signaling
cascades. A better understanding of the upstream events which
regulate the downstream effector molecules will ultimately provide
information which could ultimately be used for the design of more
effective vaccines and antiviral agents.
We have previously demonstrated that Ad rupture of lysosomal
membranes during cell entry activates the NLRP3 inﬂammasome.
Activation of the NLRP3 inﬂammasome initiates several proinﬂam-
matory pathways which are important for antiviral immunity
(Ichinohe et al., 2009) as well as the effectiveness of vaccine
adjuvants in some circumstances (Eisenbarth et al., 2008; Li et al.,
2008). Key mediators of inﬂammasome downstream signaling are
IL-1β and IL-18 (Martinon et al., 2009). Both of these cytokines have
been implicated in the proinﬂammatory response to replication
defective adenovirus vectors administrated intratracheally (Berclaz
et al., 2002) or intravenously to mice (Shayakhmetov et al., 2005).
However, a more recent study found that neither IL-1β nor NLRP3
are involved in the proinﬂammatory response to i.v. administered
Ad5 (Di Paolo et al., 2009). Instead, an interaction of Ad5 with β3
integrins on splenic marginal zone macrophages induces IL-1α
dependent inﬂammation. Further study is required to determine
whether NLRP3-dependent proinﬂammatory signals are involved in
Ad-induced inﬂammation during infections of other organs such as
the lung or heart.
Our current data suggest that the route of Ad endosomal
trafﬁcking during cell entry can greatly inﬂuence the proinﬂamma-
tory response. Previous observations have noted that Ad5F16gfp
more potently induces interferon-α release from plasmacytoid
dendritic cells during infection of human PBMCs (Iacobelli-Martinez
and Nemerow, 2007). Our current data suggest that enhanced TLR9-
dependent signaling occurs in response to Ad5F16gfp infection
when compared to infection by Ad5gfp. Additionally, targeting of
Ad5 to lysosomes upon neutralization with pooled human serum
has also been shown to greatly increase the release of proinﬂam-
matory cytokines (Zaiss et al., 2009). Our results demonstrate that
targeting Ad virions to lysosomes increases IL-1β release. This
increased release is partially due to the increased activation of TLR9
resulting in the upregulation of proIL-1β expression as well as the
inﬂammasome components, ASC and NLRP3 (Barlan et al., 2011;
Bauernfeind et al., 2009). In addition to increased activation of TLR9,targeting Ad virions to lysosomes enhances the release of cathepsin
B into the cytoplasm as the virus ruptures endosomal membranes
during cell entry. This increased release of cathepsin B by
Ad5F16gfp and Ad5+HS correlates with enhanced IL-1β release
from cells in which TLR9 is stably knocked down by shRNA.
Of the greater than 50 human adenovirus serotypes, Ad5 and
members of subgroup C viruses are the most successful at infecting
the human population, with N70% of the population thought to
possess preexisting immunity to these viruses (Ginsberg and Prince,
1994). In fact, members of subgroup B, such as Ad16, are more
commonly associated with infections of immunocompromised indi-
viduals (Leen and Rooney, 2005). While much of this difference
between subgroup C and other Ad subgroups is likely due to
differences in the Ad early genes such as immune evasion genes
encoded in the E3 transcriptional unit, subgroup C Ads may also
possess a selective advantage over other subgroups due to their ability
to more efﬁciently escape from endosomes prior to arrival at
cathepsin and TLR9 enriched lysosomes and eliciting a weaker
proinﬂammatory response.
Several intracellular bacterial pathogens are known to activate
NLRP3 by rupturing lysosomes while gaining access to the
cytoplasm during infection (Duncan et al., 2009; Willingham et
al., 2007). Thus, it seems that release of cathepsin B into the
cytoplasm has evolved as a danger-associated signal which triggers
proinﬂammatory responses and necrotic cell death of infected
macrophages (Hornung and Latz, 2010). Other nonenveloped
viruses have been shown to pass through lysosomes during cell
entry (Brabec et al., 2006; Marsh and Pelchen-Matthews, 2000;
Miyazawa et al., 2001; Qian et al., 2009; Suikkanen et al., 2003).
Reoviruses, in particular, have evolved a requirement for lysosomal
cathepsins to trigger viral capsid conformational changes which
facilitate membrane penetration (Ebert et al., 2002). While
reoviruses are thought to disrupt endosomal membranes to allow
passage of a ~70 nm diameter subvirion particle into the
cytoplasm, their ability to facilitate the transport of coninternalized
proteins and ﬂuorescently labeled dextrans across cell membranes
is much more size restricted than that of Ad virions (Agosto et al.,
2006; Ivanovic et al., 2008; Zhang et al., 2009). Cathepsin B is
28 kDa which is in the range of size selectivity reported for
reovirus membrane pores. Since reovirus appears to colocalize with
lysosomes to a similar extent as Ad5F16gfp in THP-1 cells and yet
fails to release signiﬁcant amounts of cathepsin B, it appears that
differences in the mechanism of viral membrane penetration
inﬂuence the induction of this danger-associated signal leading to
inﬂammasome activation. Thus, future studies of the location and
mechanism of nonenveloped virus cell entry may provide more
information regarding the generality of cathepsin B-associated
danger signals in innate immune responses to viral infection.
Proinﬂammatory responses to adenoviruses have greatly limited
their utility as vectors for gene therapy despite the numerous
qualities of these viruses which makes them excellent vectors for
human gene therapies (Muruve, 2004; Raper et al., 2003). Our
ﬁndings suggest that developing new Ad vectors which more
efﬁciently avoid cathepsin and TLR9 enriched lysosomes during cell
entry could greatly beneﬁt the utility of these vectors for gene
therapy. Additionally, temporary pharmacologic inhibition of lyso-
somal cysteine proteases such as cathepsin B, or TLR9 maturing
asparagine endopeptidase (AEP), could potentially reduce the
inﬂammatory response to Ad vectors. Conversely, studies with
inﬂuenza virus suggest that NLRP3 activation aids in the develop-
ment of a protective immune response (Ichinohe et al., 2009). In
some cases, NLRP3 has been also been found to contribute to the
humoral response elicited by alum-adjuvanted antigen (Eisenbarth
et al., 2008; Li et al., 2008). Thus Ad vectors employed for genetic
vaccination may beneﬁt from being more efﬁciently targeted to
cathepsin enriched lysosomes.
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Viruses and reagents
An E1/E3-deleted adenovirus encoding egfp under the control of a
cytomegalovirus promoter, Ad5gfp (Wiethoff et al., 2005), a temper-
ature sensitive mutant, ts1 (Weber, 1976) or, Ad5F16gfp (kindly
provided by Glen Nemerow (Hsu et al., 2005)) were propagated in
HEK293 cells obtained from ATCC and twice puriﬁed by cesium
chloride gradient centrifugation as previously described (Wiethoff
et al., 2005). For these studies, the ts1 virus was propagated at 39.5 °C
resulting in viral particles incapable of membrane penetration (Cotten
and Weber, 1995; Greber et al., 1996; Wiethoff et al., 2005). Viral
concentrations were determined by Bradford assay (Bio-Rad Labora-
tories, Inc.). 1 μg of protein corresponded to 4×10(9) viral particles.
Viruses were titered by serial dilution on HeLa (ATCC) cells using ﬂow
cytometry to quantify egfp expression. The speciﬁc infectivity of viral
preparations used in these studies ranged from 100 to 200 viral
particles per GFP-transducing unit (GTU). Reovirus strains T3D and
T1L were derived from lab stocks which were twice plaque puriﬁed.
Virus was propagated on L929 cells and puriﬁed by cesium chloride
density gradient centrifugation as previously described (Furlong et al.,
1988). Virus was titered by plaque assay on L929 cells.
Cell lines and reagents
THP-1 cells were obtained from ATCC and were maintained in
RPMI 1640 media, supplemented with 10% FBS, 100 IU/ml
penicillin, 1 mg/ml streptomycin, 0.25 μg/ml amphotericin B, non-
essential amino acids, 1 mM sodium pyruvate, 10 mM HEPES buffer
and 2 mM glutamine from Mediatech and HyClone. THP-1 cells
were differentiated by overnight stimulation with 100 nM phorbol-
12-myristate-13-acetate (PMA; EMD Chemicals) to macrophage-
like cells. HEK293 and HeLa cells were maintained in DMEM
(Mediatech) containing the above additives used in the RPMI 1640
media. Murine L929 (L) cells were maintained in Joklik's MEM
(Lonza) supplemented to contain 5% fetal bovine serum (FBS),
2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, and
25 ng/ml amphotericin B (Sigma-Aldrich). All other chemical
reagents were from Fisher Chemicals.
Measurement of IL-1β secretion by ELISA
50,000 THP-1 cells per well were plated in a 96-well plate and
differentiated with 100 nM PMA for 16 h. Cells were then rested in
serum free media for 2 h. A subset of cells was then primed with
30 ng/ml PAM3CSK4 (InvivoGen) for 2 h. Both primed and
unprimed cells were then infected with various amounts of
Ad5gfp (with 10% FBS or 10% pooled human AB serum (Sigma-
Aldrich)), Ad5F16gfp, T3D and T1L. At various time points post
infection, the supernatants were collected and secreted IL-1β was
quantiﬁed with Human IL-1β ELISA Ready-SET-Go! kit obtained
from eBioscience.
Saporin cell viability assay
Lyophilized saporin (Sigma-Aldrich) was reconstituted with
water to 1 mg/ml stock solution. Working concentration in
complete media was 50 μg/ml. 20,000 HeLa cells per well in a 96-
well plate were infected with serial dilutions of Ad5gfp or
Ad5F16gfp in the presence of saporin. 16 h post infection, 0.02%
MTT (cat# M92050, RPI Corp.) was added to the media for 2 h
incubation. Cells were then washed with PBS and dissolved with
DMSO for 15 min. Color intensity was measured by Biotech ELx800
plate reader using KC Junior software.Measurement of cathepsin B release into cytoplasm
PMA-differentiated THP-1 cells (2×10(6)/well) in 6 well plates
were treated with media alone, 100, 300 or 1000 GTU/cell of Ad5gfp,
30, 100 or 300 GTU/cell of Ad5F16gfp Ad5gfp+10% human serum for
1 h. Cells were then permeabilized with ice cold 50 μg/ml digitonin
(Calbiochem) in PBS pH 7.4 and 1 mM PMSF (MP Biomedicals) for
15 min at 4 °C which selectively permeabilizes the plasma membrane
while leaving intracellular membranes intact (Ghavami et al., 2008).
Cell extract using 0.1% triton X-100 was used as a positive control for
cathepsin B release. These cytosolic extracts were subjected to SDS-
PAGE, transferred to nitrocellulose membranes and immunoblotted
for cathepsin B (Santa Cruz cat# sc-13985) and Beta-actin (Sigma).
Immunoﬂuorescence microscopy
Differentiated THP-1 cells were plated on coverslips coated with
ﬁbronectin (Sigma-Aldrich) and then infected with Ad5gfp,
Ad5F16gfp, ts1, T1L, or T3D. Cells were then ﬁxed with 4%
paraformaldehyde (Electron Microscopy Sciences) and permeabilized
with 0.1% TritonX-100 (Sigma-Aldrich). Cells were immunostained
with polyclonal reovirus Abs and LAMP-1 mAb from eBioscience.
Secondary Alexa Fluor 488- and 568-conjugated Abs were used to
visualize reovirus infection and lysosomes, respectively. Ad5gfp,
Ad5F16gfp and ts1 were prelabeled with Dylight 488 NHS-Ester
Fluorophores, according to the manufacturer's protocol prior to use.
Labeling did not signiﬁcantly affect viral infectivity. Hoechst stain
from ImmunoChemistry Technologies was used to counterstain nuclei
before coverslips were mounted on glass slides with ProLong Gold
from Invitrogen. Z-stack images were acquired with a DeltaVision
microscope (Applied Precision) using a CoolSnap HQ digital camera
(Photometrics) with a 1.4-numerical aperture (NA) 100× objective
lens, and deconvolved with SoftWorx deconvolution software
(Applied Precision).
Quantiﬁcation of lysosomal localization
Deconvolved images were analyzed for the localization of virus
particles in relation to lysosomes with the “multichannel view” plugin
of MacBiophotonics ImageJ. The number of units of colocalization of
virus with LAMP-1 per cell was counted for 25 infected cells for each
virus type. The signiﬁcance of observed differences between the
distributions of the number of dually positive puncta per cell was
determined by a two-tailed t-test assuming equal variance using
Microsoft Excel.
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